All the news Showing 10 of 175 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources 'Fantastic' data on Novartis' first-in-class hep C antiviral Pharma Times / 01 April 2011 Well-known statin could be recycled as HCV therapy supplement EASL / 01 April 2011 EASL Clinical Practice Guidelines: Management of Hepatitis C Virus Infection EASL / 31 March 2011 Interim Phase 2 Data Showed Rapid Viral Response to VX-222 in Combination with Telaprevir, Pegylated-Interferon and Ribavirin Among People With Hepatitis C Business Wire / 31 March 2011 Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b Clinical Trial of PPI-461, a Novel, Potent Broadly-Active Hepatitis C Virus (HCV) Inhibitor Business Wire / 30 March 2011 Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes PR Newswire / 30 March 2011 Achillion ACH-1625 hepatitis drug shows promise in mid-stage trial Reuters / 30 March 2011 Next Stage for Biotron's Hep C Drug Hepatitis Central / 23 March 2011 More Support for Genetic Testing of Hepatitis C Patients Internal Medicine News / 16 March 2011 iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061 PR Newswire / 15 March 2011 ← Prev1...1415161718Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds